MaxLinear ($MXL) Director Awarded 15,741 RSUs in Amended Filing
MAXLINEAR, INC
Subscribe to track MXL
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
MaxLinear ($MXL) Director Awarded 15,741 RSUs in Amended Filing
Company: MAXLINEAR, INC (MXL) Form: 4/A | Filed: 2025-10-10 Significance: Low
Insider: MOYER ALBERT J Title: null | Relationship: Director
Transaction: • Type: Grant • Shares: 15,741 Restricted Stock Units • Price: $0.00 • Value: $0 • Owned After: 15,741
Key Insight: This is an amended filing (4/A) to correct the number of RSUs granted to a director. The grant is part of standard director compensation and does not represent an open-market transaction.
Market Context: The transaction is a routine equity award, which typically has a neutral market impact as it's an expected form of compensation. The vesting period is approximately one year.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: MAXLINEAR, INC (MXL)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A Director at MaxLinear, Inc. was granted 15,741 Restricted Stock Units (RSUs) as part of their compensation. This Form 4/A was filed to amend a previous filing from May 2025, correcting the number of units reported.
- Market Impact: The market impact is expected to be neutral. This is a routine, non-cash equity award for a board member, not an open-market purchase reflecting new insider sentiment.
Company Information
| Field | Value |
|---|---|
| Company | MAXLINEAR, INC |
| Ticker Symbol | MXL |
| CIK | 0001288469 |
| Industry | SEMICONDUCTORS & RELATED DEVICES [3674] |
Insider Information
| Field | Value |
|---|---|
| Name | MOYER ALBERT J |
| CIK | 0001016366 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4/A |
| Transaction Date | 2025-05-20 |
| Transaction Code | A (Grant) |
| Security Type | Restricted Stock Units |
| Shares Involved | 15,741 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 15,741 |
| Ownership Type | Direct |
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: Equity grants to directors are a standard part of compensation packages and are not indicative of an insider using their own capital to increase their stake. This transaction does not signal a change in the insider's view of the company's future prospects beyond their continued service on the board. The fact that it is a corrective filing further diminishes its immediate market relevance.
Volume & Sentiment
- Expected Volume Impact: Negligible. As this is not an open-market transaction, it will not directly impact trading volume.
- Sentiment Indicator: Neutral. This is a routine corporate governance action, not a bullish or bearish market signal.
Investment Insights
Positive Market Indicators
- The grant aligns the director's interests with those of shareholders, as the value of the RSUs is tied to the company's future stock performance.
Risk Factors
- No immediate risk factors are apparent from this filing. It is a standard compensatory grant.
Key Takeaways
- Corrective Filing: The primary purpose of this Form 4/A is to correct an error in a previous filing, specifically the number of RSUs granted.
- Standard Compensation: The award of RSUs is a common method for compensating non-employee directors and is not an opportunistic trade.
- Future Vesting: The shares will not be owned outright until they vest on the earlier of May 1, 2026, or the next annual stockholder meeting, contingent on the director's continued service.
Contextual Analysis
Timing Significance
This filing was made in October to correct a transaction from May. The delay is related to correcting the record, not to any new market-moving event.
Transaction Context
According to the footnotes, each RSU represents a right to receive one share of common stock. The filing explicitly states, "This amendment is being filed to correct the number of RSUs reported in the Form 4 filed May 22, 2025." This confirms the administrative nature of the filing.
Company Context
MaxLinear operates in the semiconductor industry. This grant is part of its regular equity compensation cycle for its board of directors, as governed by its 2010 Equity Incentive Plan.
Risk Assessment
Risk Level: Low
Risk Factors
- Dilution: Equity grants can lead to minor shareholder dilution over time, but this is a standard and expected practice.
- Compensation Structure: The value of the grant is dependent on future stock performance, which carries inherent market risk.
Market Considerations
- Industry Trends: The semiconductor industry is cyclical and subject to global supply chain and demand dynamics.
- Compensation Benchmarking: This grant is likely in line with compensation practices for directors at peer companies.
IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.
Analysis generated on 2025-10-10 | Data source: SEC EDGAR
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.